| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6150632 | Contemporary Clinical Trials | 2015 | 5 Pages |
Abstract
The study will be sufficiently powered to provide data primarily regarding the safety of dual therapy with rivaroxaban and ticagrelor over the traditional triple therapy in patients with AF undergoing PCI at 12Â months. It will also provide important information regarding the efficacy of the two different antithrombotic regimens. (ClinicalTrials.gov identifier: NCT02334254).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Fei Gao, Hua Shen, Zhi Jian Wang, Shi Wei Yang, Xiao Li Liu, Yu Jie Zhou,